Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 8350158, 7 pages
http://dx.doi.org/10.1155/2016/8350158
Research Article

No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study

1Copenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark
2Department of Public Health, Section of Biostatistics, University of Copenhagen, Øster Farimagsgade 5, 1710 Copenhagen K, Denmark
3Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark

Received 12 May 2016; Revised 31 August 2016; Accepted 14 September 2016

Academic Editor: Marco Bugliani

Copyright © 2016 Steffen U. Thorsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Atkinson, G. S. Eisenbarth, and A. W. Michels, “Type 1 diabetes,” The Lancet, vol. 383, no. 9911, pp. 69–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Knip and O. Simell, “Environmental triggers of type 1 diabetes,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 7, Article ID a007690, 2012. View at Publisher · View at Google Scholar
  3. L. Groop and F. Pociot, “Genetics of diabetes—are we missing the genes or the disease?” Molecular and Cellular Endocrinology, vol. 382, no. 1, pp. 726–739, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Redondo, J. Jeffrey, P. R. Fain, G. S. Eisenbarth, and T. Orban, “Concordance for islet autoimmunity among monozygotic twins,” The New England Journal of Medicine, vol. 359, no. 26, pp. 2849–2850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Svensson, A. Lyngaae-Jørgensen, B. Carstensen, L. B. Simonsen, and H. B. Mortensen, “Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time,” Pediatric Diabetes, vol. 10, no. 4, pp. 248–254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. C. Patterson, E. Gyürüs, J. Rosenbauer et al., “Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase,” Diabetologia, vol. 55, no. 8, pp. 2142–2147, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Patterson, G. G. Dahlquist, E. Gyürüs, A. Green, and G. Soltész, “Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study,” The Lancet, vol. 373, no. 9680, pp. 2027–2033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A.-G. Ziegler, M. Pflueger, C. Winkler et al., “Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children,” Journal of Autoimmunity, vol. 37, no. 1, pp. 3–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. In't Veld, “Insulitis in human type 1 diabetes: the quest for an elusive lesion,” Islets, vol. 3, no. 4, pp. 131–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. S. Hampe, “B cells in autoimmune diseases,” Scientifica, 2012, http://www.ncbi.nlm.nih.gov/pubmed/2380790 View at Google Scholar
  11. P. Leete, A. Willcox, L. Krogvold et al., “Differential insulitic profiles determine the extent of β-cell destruction and the age at onset of type 1 diabetes,” Diabetes, vol. 65, no. 5, pp. 1362–1369, 2016. View at Publisher · View at Google Scholar
  12. M. D. Pescovitz, C. J. Greenbaum, H. Krause-Steinrauf et al., “Rituximab, B-lymphocyte depletion, and preservation of beta-cell function,” The New England Journal of Medicine, vol. 361, no. 22, pp. 2143–2152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Yu, K. Herold, H. Krause-Steinrauf et al., “Rituximab selectively suppresses specific islet antibodies,” Diabetes, vol. 60, no. 10, pp. 2560–2565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Kawasaki, H. Takino, M. Yano et al., “Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease,” Diabetes, vol. 43, no. 1, pp. 80–86, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. S. U. Thorsen, S. Eising, H. B. Mortensen et al., “Systemic levels of CCL2, CCL3, CCL4 and CXCL8 differ according to age, time period and season among children newly diagnosed with type 1 diabetes and their healthy siblings,” Scandinavian Journal of Immunology, vol. 80, no. 6, pp. 452–461, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. K. F. Lynch, B. Lernmark, J. Merlo, C. M. Cilio, S.-A. Ivarsson, and Å. Lernmark, “Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype,” Journal of Perinatology, vol. 28, no. 3, pp. 211–217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Sjöroos, A. Iitiä, J. Ilonen, H. Reijonen, and T. Lövgren, “Triple-label hybridization assay for type-1 diabetes-related HLA alleles,” BioTechniques, vol. 18, no. 5, pp. 870–877, 1995. View at Google Scholar · View at Scopus
  18. T. M. Therneau and P. M. Grambsch, Modeling Survival Data: Extending the Cox Model, Springer, 2000.
  19. A. E. Long, K. M. Gillespie, S. Rokni, P. J. Bingley, and A. J. K. Williams, “Rising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosis,” Diabetes, vol. 61, no. 3, pp. 683–686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Brorsson and F. Pociot, “Type 1 diabetes genetics consortium. shared genetic basis for Type 1 diabetes, islet autoantibodies, and autoantibodies associated with other immune-mediated diseases in families with Type 1 Diabetes,” Diabetes Care, vol. 38, supplement 2, pp. S8–S13, 2015. View at Google Scholar
  21. C. A. Brorsson, S. Onengut, W.-M. Chen et al., “Novel association between immune-mediated susceptibility loci and persistent autoantibody positivity in type 1 diabetes,” Diabetes, vol. 64, no. 8, pp. 3017–3027, 2015. View at Publisher · View at Google Scholar
  22. C. Törn, D. Hadley, H.-S. Lee et al., “Role of type 1 diabetes-associated SNPs on risk of autoantibody positivity in the TEDDY study,” Diabetes, vol. 64, no. 5, pp. 1818–1829, 2015. View at Publisher · View at Google Scholar
  23. H. Reijonen, T. L. Daniels, A. Lernmark, and G. T. Nepom, “GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65,” Diabetes, vol. 49, no. 10, pp. 1621–1626, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. C. S. Hampe, “Protective role of anti-idiotypic antibodies in autoimmunity—lessons for type 1 diabetes,” Autoimmunity, vol. 45, no. 4, pp. 320–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Wang, A. Zhang, Y. Liu et al., “Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse,” PLoS ONE, vol. 7, no. 2, Article ID e32515, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Richardson, K. A. McLaughlin, T. J. Brown et al., “Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes,” Autoimmunity, vol. 46, no. 6, pp. 375–381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Knip, M. Kukko, P. Kulmala et al., “Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes,” American Journal of Medical Genetics, vol. 115, no. 1, pp. 48–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Pihoker, L. K. Gilliam, C. S. Hampe, and Å. Lernmark, “Autoantibodies in diabetes,” Diabetes, vol. 54, supplement 2, pp. S52–S61, 2005. View at Publisher · View at Google Scholar · View at Scopus